Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antipsychotics in the elderly.

J Rosen1, S Bohon, S Gershon

  • 1Western Psychiatric Institute and Clinic, Pittsburgh, PA.

Acta Psychiatrica Scandinavica. Supplementum
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phenotypic Convergence Is Stronger and More Frequent in Herbivorous Fishes.

Integrative and comparative biology·2024
Same author

Ti <sub></sub>C <sub></sub> MXenes with fully saturated and thermally stable Cl terminations.

Nanoscale advances·2022
Same author

Correction: Genetic influences on central and peripheral nervous system activity during fear conditioning.

Translational psychiatry·2022
Same author

Genetic influences on central and peripheral nervous system activity during fear conditioning.

Translational psychiatry·2022
Same author

Microscopic evidence for Mn-induced long range magnetic ordering in MAX phase compounds.

Journal of physics. Condensed matter : an Institute of Physics journal·2020
Same author

Immunohistochemistry analysis of itch and pain mediators in nonmelanoma skin cancer.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same journal

Use of psychotropic drugs during pregnancy and breast-feeding.

Acta psychiatrica Scandinavica. Supplementum·2015
Same journal

Getting depression clinical practice guidelines right: time for change?

Acta psychiatrica Scandinavica. Supplementum·2013
Same journal

Manipulating melatonin in managing mood.

Acta psychiatrica Scandinavica. Supplementum·2013
Same journal

Chronobiology of mood disorders.

Acta psychiatrica Scandinavica. Supplementum·2013
Same journal

It is time we managed depression: the emerging role of chronobiology. Preface.

Acta psychiatrica Scandinavica. Supplementum·2013
Same journal

Lifestyle management of unipolar depression.

Acta psychiatrica Scandinavica. Supplementum·2013
See all related articles

Neuroleptic medications can help manage agitation and psychosis in elderly patients, but careful monitoring and dose reduction are crucial due to potential overuse and environmental factors. Low doses of high-potency agents appear safest.

Area of Science:

  • Geriatric Psychiatry
  • Psychopharmacology
  • Clinical Neurology

Background:

  • Neuroleptics are frequently prescribed for geriatric patients, often for conditions beyond typical indications in younger populations.
  • Despite widespread use in elderly patients with organic brain syndromes, rigorous double-blind, placebo-controlled studies are limited.
  • Existing research presents conflicting results regarding neuroleptic efficacy in the elderly.

Purpose of the Study:

  • To evaluate the efficacy and safety of neuroleptic treatment in the geriatric population.
  • To address the potential for overuse of neuroleptics in elderly individuals.
  • To provide guidance on appropriate neuroleptic use, including dose adjustment and discontinuation.

Main Methods:

  • Review of existing double-blind, placebo-controlled studies on neuroleptic use in the elderly.

Related Experiment Videos

  • Analysis of evidence for neuroleptic responsiveness in symptoms like agitation, behavioral dyscontrol, and psychosis.
  • Consideration of side-effect profiles and comparative data for different neuroleptic agents.

    • Main Results:

    • Sufficient evidence suggests neuroleptics can be effective for agitation, behavioral dyscontrol, and psychosis in elderly patients.
    • Elderly patients with schizophrenia or other psychotic disorders may also benefit from neuroleptic therapy.
    • Low doses of high-potency neuroleptic agents appear to be safer and better tolerated in this population.

    Conclusions:

    • Clear symptom checklists are essential to prevent neuroleptic overuse in the elderly.
    • Periodic dose reduction and discontinuation should be considered, as symptoms may be time-limited or environmentally related.
    • Regular assessment of both therapeutic effects and side effects is imperative; low-dose, high-potency agents are recommended.